Sep 20, 2023 07:41AM
Sep 15, 2022 07:00AM
Jan 10, 2022 07:00AM
Jan 10, 2022 07:00AM
Jan 4, 2022 07:00AM
Jan 4, 2022 07:00AM
Nov 16, 2021 03:40AM UPDATE: JPMorgan Downgrades Orchard Therapeutics (ORTX) to Underweight on Lack of Meaningful Short-term Catalysts and Negative Sentiment
Aug 18, 2021 03:58AM
Jun 1, 2021 06:45AM
Jan 11, 2021 07:13AM
Jan 11, 2021 07:00AM
Jan 11, 2021 07:00AM
Jan 5, 2021 07:00AM
Jan 5, 2021 07:00AM Orchard Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Jan 13, 2020 07:00AM
Jan 13, 2020 07:00AM
Jan 6, 2020 07:00AM
Jan 6, 2020 07:00AM
Jun 6, 2019 05:51AM
Jun 5, 2019 07:59PM
Jun 5, 2019 07:59PM Orchard Therapeutics Announced Pricing of Public Offering
Jun 3, 2019 04:10PM
Jun 3, 2019 04:05PM
Jun 3, 2019 04:05PM
Jan 7, 2019 08:00AM
Jan 2, 2019 04:01PM
Nov 26, 2018 04:05AM
Nov 5, 2018 07:00AM Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option
Oct 31, 2018 05:51AM
Oct 30, 2018 10:21PM

276,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All